Vident Investment Advisory’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,514
Closed -$4.13M 11
2023
Q2
$4.13M Buy
22,514
+701
+3% +$101K 0.14% 169
2023
Q1
$2.91M Buy
21,813
+19,057
+691% +$2.24M 0.09% 234
2022
Q4
$219K Sell
2,756
-35,652
-93% -$2.51M 0.01% 1006
2022
Q3
$2.21M Sell
38,408
-2,316
-6% -$150K 0.07% 315
2022
Q2
$2.23M Buy
40,724
+3,031
+8% +$176K 0.07% 351
2022
Q1
$2.85M Buy
+37,693
New +$2.57M 0.07% 296

Other funds holding ACLS

Vident Investment Advisory's ACLS Position: Q3 2023 in Review

Vident Investment Advisory sold out of Axcelis (ACLS) in Q3 2023, closing a stake of 22,514 shares — an estimated $4.13M sold.

Vident Investment Advisory first reported a position in ACLS in Q1 2022 and held it in 6 quarters. The position peaked at $4.13M in Q2 2023. 420 funds tracked by Wall St. Rank hold ACLS as of Q3 2023.

  • Vident Investment Advisory reported no remaining Axcelis position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 22,514 Axcelis shares in Q3 2023, an estimated $4.13M.
  • Vident Investment Advisory first reported a position in Axcelis in Q1 2022 and held it in 6 quarters.
  • Vident Investment Advisory's Axcelis position peaked at $4.13M in Q2 2023.
  • 420 funds tracked by Wall St. Rank held Axcelis as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.